There were 1,569 press releases posted in the last 24 hours and 358,518 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Protalix BioTherapeutics Announces Phase II Clinical Trial Results for alidornase alfa in Cystic Fibrosis Presented at the 40th European Cystic Fibrosis Society Conference

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image